Contact us

877-469-1TRM
424-208-8866

Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity (IT-MATTERS)

Phase III Study of LI [Multikine®] Plus SOC (Surgery + Radiotherapy or Surgery + Concurrent Radiochemotherapy) in Subjects With Advanced Primary Squamous Cell Carcinoma of the Oral Cavity/Soft Palate vs. SOC Only

For more information, please visit ClinicalTrials.gov

Patient Population Investigational Product(s) Phase Status
Squamous Cell Carcinoma of the Oral Cavity Multikine III Open and Accruing